J. Marc Simard

Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.

Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA.

WPP Group USA, Inc. provides communications and media management services. The company is headquartered in New York, NY.

Aminex Therapeutics, Inc. operates as a drug development company, which focuses on a novel immunotherapy for the treatment of cancer. The company was founded by James B. Skaggs in 2009 and is headquartered in Kirkland, WA.

Carson Group provides financial information services. The firm specializes in global shareholder research and related advisory services. The company was foundedd by David M. Geliebter and is headquartered in New York, NY.

Evolution Capital Management LLC (Evolution) is an independent registered investment advisor and alternative investment manager headquartered in Crystal Bay, Nevada. The firm was founded by Michael Lerch in 2002 and is a subsidiary of Tiger Trust. Evolution manages private investment funds for corporations, pension plans, foundations, trusts, estates, and high net worth individuals.

Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.

Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York.

Access Scientific LLC develops vascular access devices. It offers The PICC WAND a clinically proven technique for placement of PICC-introducer/peelable sheaths. The company was founded in 2004 and is headquartered in San Diego, CA.

Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA.

ASCEND Therapeutics US LLC operates as a specialty pharmaceutical company which focuses on women’s health. The firm develops and markets pharmaceutical transdermal therapies. Its products include EstroGel, a non-patch transdermal estrogen therapy. The company was founded by Jay A. Bua in 2002 and is headquartered in Herndon, VA.

Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands.

ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors.

Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy.

Martin Pharmaceuticals, Inc. engages in manufacturing, fabricating and processing drugs. The company was founded by David M. Geliebter and Sven M. Jacobson and is headquartered in New York, NY.

Woolsey Pharmaceuticals, Inc. operates as a single-drug entity. It is focused on the treatment of rare, neurodegenerative diseases with its compound BRAVYL (Fasudil). The company was founded in 2019 and is headquartered in New York, NY.

Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA.

Learmont Pharmaceuticals, Inc. operates as a pharmaceutical company. The company is based in New York, NY. The company was founded by David M. Geliebter.